MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) will participate in an institutional investor conference next week, providing investors with an opportunity to hear the company’s perspective on the commercialization of …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.